Mark Tuszynski
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment (NCT05040217) | Mark Tuszynski | 2022-02-07 |
Track Mark Tuszynski automatically
Every clearance here is in the API, with alerts when new ones post.